Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 121 of 121 entries
View as:

The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children

Phase: N/A Priority: Normal
NCT ID: NCT06205563 Org: User:
Start: 05/01/24 End: 12/30/26 Due: 12/30/27

Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Phase: N/A Priority: Normal
NCT ID: NCT04310787 Org: User:
Start: 05/15/20 End: 12/31/24 Due: 12/31/25

Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06763848 Org: User:
Start: 04/25/25 End: 12/31/26 Due: 12/31/27

PRevention of OsTEoporotiC FracTure 2 Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06134908 Org: User:
Start: 01/13/24 End: 06/30/27 Due: 06/30/28

Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02417207 Org: User:
Start: 04/30/15 End: 04/30/18 Due: 04/30/19

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Phase: N/A Priority: Normal
NCT ID: NCT02838810 Org: User:
Start: 06/30/16 End: 12/31/19 Due: 12/31/20

Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT03521336 Org: User:
Start: 09/01/19 End: 12/31/21 Due: 12/31/22

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism

Phase: N/A Priority: Normal
NCT ID: NCT01441804 Org: User:
Start: 05/31/11 End: 08/31/14 Due: 08/31/15

Origin of the Neonatal Gut Microbiota and Probiotic Intervention

Phase: N/A Priority: Normal
NCT ID: NCT06241222 Org: User:
Start: 01/01/18 End: 12/31/21 Due: 12/31/22

The Activation of Hippo Pathway in Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT03151954 Org: User:
Start: 04/20/17 End: 07/31/20 Due: 07/31/21

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05545436 Org: User:
Start: 09/20/22 End: 06/30/23 Due: 06/30/24

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Phase: N/A Priority: Normal
NCT ID: NCT01935635 Org: User:
Start: 01/31/15 End: 12/31/19 Due: 12/31/20

Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02219854 Org: User:
Start: 07/31/14 End: 07/31/20 Due: 07/31/21

MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06825572 Org: User:
Start: 04/01/25 End: 09/30/26 Due: 09/30/27

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Phase: N/A Priority: Normal
NCT ID: NCT05484908 Org: User:
Start: 08/12/22 End: 12/31/24 Due: 12/31/25

Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02779465 Org: User:
Start: 06/30/16 End: 12/31/26 Due: 12/31/27

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Phase: N/A Priority: Normal
NCT ID: NCT03920618 Org: User:
Start: 02/21/19 End: 12/31/24 Due: 12/31/25

Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs: A Propensity Analysis

Phase: N/A Priority: Normal
NCT ID: NCT04258098 Org: User:
Start: 01/01/11 End: 05/12/19 Due: 05/12/20

Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF

Phase: N/A Priority: Normal
NCT ID: NCT04597164 Org: User:
Start: 12/22/20 End: 12/31/24 Due: 12/31/25

A RCT of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for GA

Phase: N/A Priority: Normal
NCT ID: NCT02017392 Org: User:
Start: 12/31/13 End: 04/30/14 Due: 04/30/15

Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02164136 Org: User:
Start: 06/30/14 End: 06/30/23 Due: 06/30/24